Primary |
Product Used For Unknown Indication |
48.6% |
Hypothyroidism |
21.6% |
Pain |
10.8% |
Basedow's Disease |
5.4% |
Atrial Fibrillation |
2.7% |
Blood Thyroid Stimulating Hormone Increased |
2.7% |
Generalised Resistance To Thyroid Hormone |
2.7% |
Pregnancy |
2.7% |
Tachycardia Foetal |
2.7% |
|
Toxicity To Various Agents |
9.5% |
Foetal Exposure During Pregnancy |
4.8% |
Hepatic Adenoma |
4.8% |
Liver Injury |
4.8% |
Maternal Exposure During Pregnancy |
4.8% |
Metastases To Abdominal Cavity |
4.8% |
Palmar-plantar Erythrodysaesthesia Syndrome |
4.8% |
Pulmonary Embolism |
4.8% |
Pulmonary Malformation |
4.8% |
Respiratory Failure |
4.8% |
Stomatitis |
4.8% |
Tachycardia Foetal |
4.8% |
Therapeutic Response Unexpected With Drug Substitution |
4.8% |
Thyroid Cancer Recurrent |
4.8% |
Urinary Tract Infection |
4.8% |
Use Of Accessory Respiratory Muscles |
4.8% |
Uterine Hypotonus |
4.8% |
Vena Cava Thrombosis |
4.8% |
Vitamin D Deficiency |
4.8% |
Vomiting |
4.8% |
|
Secondary |
Product Used For Unknown Indication |
57.7% |
Hypothyroidism |
13.5% |
Hypertension |
5.8% |
Myelodysplastic Syndrome |
5.8% |
Post Procedural Complication |
5.8% |
Gastrooesophageal Reflux Disease |
3.8% |
Chronic Obstructive Pulmonary Disease |
1.9% |
Depression |
1.9% |
Diabetes Mellitus |
1.9% |
Plasma Cell Myeloma |
1.9% |
|
Muscular Weakness |
11.8% |
Completed Suicide |
5.9% |
Dizziness |
5.9% |
Feeling Abnormal |
5.9% |
Milk-alkali Syndrome |
5.9% |
Nausea |
5.9% |
Overdose |
5.9% |
Pancytopenia |
5.9% |
Renal Failure |
5.9% |
Respiratory Arrest |
5.9% |
Serotonin Syndrome |
5.9% |
Transient Ischaemic Attack |
5.9% |
Tremor |
5.9% |
Urinary Tract Infection |
5.9% |
Weight Decreased |
5.9% |
White Blood Cell Count Decreased |
5.9% |
|
Concomitant |
Product Used For Unknown Indication |
21.8% |
Plasma Cell Myeloma |
15.2% |
Multiple Sclerosis |
10.2% |
Chronic Myeloid Leukaemia |
7.3% |
Type 2 Diabetes Mellitus |
5.3% |
Myelodysplastic Syndrome |
4.6% |
Depression |
4.3% |
Hypertension |
4.3% |
Osteoporosis |
4.0% |
Immunodeficiency Common Variable |
3.0% |
Type 1 Diabetes Mellitus |
2.6% |
Actinic Keratosis |
2.3% |
Urinary Tract Infection |
2.3% |
Breast Cancer |
2.0% |
Hypoparathyroidism |
2.0% |
Thyroid Cancer |
2.0% |
Tuberous Sclerosis |
2.0% |
Acromegaly |
1.7% |
Blood Cholesterol Increased |
1.7% |
Blood Pressure |
1.7% |
|
Vomiting |
12.3% |
Tremor |
8.0% |
Weight Decreased |
7.2% |
Urinary Tract Infection |
6.5% |
Nausea |
5.8% |
Renal Failure Acute |
5.1% |
White Blood Cell Count Decreased |
5.1% |
Anaphylactic Reaction |
4.3% |
Platelet Count Decreased |
4.3% |
Unresponsive To Stimuli |
4.3% |
Urticaria |
4.3% |
Weight Increased |
4.3% |
Deep Vein Thrombosis |
3.6% |
Fatigue |
3.6% |
Pulmonary Embolism |
3.6% |
Renal Failure |
3.6% |
Somnolence |
3.6% |
Vision Blurred |
3.6% |
Visual Impairment |
3.6% |
Drug Ineffective |
2.9% |
|